BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+2.31%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$3.71B
AUM Growth
+$3.71B
Cap. Flow
+$214M
Cap. Flow %
5.78%
Top 10 Hldgs %
63.73%
Holding
72
New
5
Increased
7
Reduced
10
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ROIV icon
26
Roivant Sciences
ROIV
$8.54B
$32M 0.86%
+2,742,409
New +$32M
CGEM icon
27
Cullinan Oncology
CGEM
$453M
$28.9M 0.78%
3,196,701
ETNB icon
28
89bio
ETNB
$1.36B
$28.5M 0.77%
1,846,154
THRD
29
DELISTED
Third Harmonic Bio
THRD
$27.9M 0.75%
4,365,933
EPIX icon
30
ESSA Pharma
EPIX
$11.3M
$27M 0.73%
8,748,629
OVID icon
31
Ovid Therapeutics
OVID
$91.7M
$26.3M 0.71%
6,851,051
ANTX icon
32
AN2 Therapeutics
ANTX
$33.6M
$25.1M 0.68%
1,563,963
LXRX icon
33
Lexicon Pharmaceuticals
LXRX
$396M
$21.8M 0.59%
19,995,332
ACIU icon
34
AC Immune
ACIU
$228M
$21.2M 0.57%
7,428,379
RLAY icon
35
Relay Therapeutics
RLAY
$700M
$19.9M 0.54%
2,365,805
-754,716
-24% -$6.35M
ALLK
36
DELISTED
Allakos
ALLK
$19.4M 0.52%
8,552,417
-100,000
-1% -$227K
SLN
37
Silence Therapeutics
SLN
$235M
$14.8M 0.4%
1,508,416
CBIO
38
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$14.3M 0.39%
9,544,262
NAMS icon
39
NewAmsterdam Pharma
NAMS
$2.82B
$14.1M 0.38%
1,521,948
ITOS
40
DELISTED
iTeos Therapeutics
ITOS
$13.8M 0.37%
1,259,476
-551,359
-30% -$6.04M
IMA
41
ImageneBio, Inc. Common Stock
IMA
$154M
$13.7M 0.37%
3,169,164
VSTM icon
42
Verastem
VSTM
$568M
$13.7M 0.37%
1,685,219
CALT
43
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$13.7M 0.37%
750,000
STRO icon
44
Sutro Biopharma
STRO
$83.1M
$11.6M 0.31%
3,347,946
IMVT icon
45
Immunovant
IMVT
$2.85B
$11.5M 0.31%
+300,000
New +$11.5M
VIGL
46
DELISTED
Vigil Neuroscience
VIGL
$9.78M 0.26%
1,813,633
VERV
47
DELISTED
Verve Therapeutics
VERV
$8.62M 0.23%
650,000
CTMX icon
48
CytomX Therapeutics
CTMX
$343M
$8.51M 0.23%
6,595,801
TCRX icon
49
TScan Therapeutics
TCRX
$103M
$7.65M 0.21%
2,989,474
JSPR icon
50
Jasper Therapeutics
JSPR
$44.2M
$6.93M 0.19%
9,900,000